Advertisement
Screener

10x Genomics, Inc. (TXG) Increase (Decrease) in Employee Related Liabilities

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Increase (Decrease) in Employee Related Liabilities

10x Genomics, Inc. (TXG) reported Increase (Decrease) in Employee Related Liabilities of -$17.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-07

  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $3.12M, a 20.49% decline year-over-year.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$20.96M.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $5.36M, a 43.82% increase year-over-year.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $10.10M, a 2.19% increase year-over-year.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was $7.65M, a 109.28% increase from fiscal 2024.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was $3.65M.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2023 was -$2.64M, a 336.71% decline from fiscal 2022.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2022 was $1.11M, a 93.18% decline from fiscal 2021.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 12 month
2026-06-30$3.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$17.83M
10-Q · filed 2026-08-07
-$12.47M
derived: sum of 3 quarters · filed 2026-08-07
-$2.37M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$20.96M
10-Q · filed 2026-05-08
-$15.59M
derived: sum of 2 quarters · filed 2026-05-08
-$5.49M
derived: sum of 3 quarters · filed 2026-05-08
-$1.56M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$5.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$15.46M
derived: sum of 2 quarters · filed 2026-02-13
$19.39M
derived: sum of 3 quarters · filed 2026-08-07
$7.65M
10-K · filed 2026-02-13
2025-09-30$10.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$14.03M
derived: sum of 2 quarters · filed 2026-08-07
$2.28M
10-Q · filed 2025-11-07
$6.01M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$3.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$7.82M
10-Q · filed 2026-08-07
-$4.09M
derived: sum of 3 quarters · filed 2026-08-07
$5.80M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$11.74M
10-Q · filed 2026-05-08
-$8.02M
derived: sum of 2 quarters · filed 2026-05-08
$1.87M
derived: sum of 3 quarters · filed 2026-05-08
$1.29M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$3.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$13.61M
derived: sum of 2 quarters · filed 2026-02-13
$13.03M
derived: sum of 3 quarters · filed 2026-02-13
$3.65M
10-K · filed 2026-02-13
2024-09-30$9.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$9.30M
derived: sum of 2 quarters · filed 2025-11-07
-$75.00K
10-Q · filed 2025-11-07
$1.46M
derived: sum of 4 quarters · filed 2026-02-13
2024-06-30-$580.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$9.96M
10-Q · filed 2025-08-08
-$8.43M
derived: sum of 3 quarters · filed 2026-02-13
-$2.28M
derived: sum of 4 quarters · filed 2026-02-13
2024-03-31-$9.38M
10-Q · filed 2025-05-09
-$7.85M
derived: sum of 2 quarters · filed 2026-02-13
-$1.70M
derived: sum of 3 quarters · filed 2026-02-13
$3.11M
derived: sum of 4 quarters · filed 2026-02-13
2023-12-31$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$7.68M
derived: sum of 2 quarters · filed 2026-02-13
$12.49M
derived: sum of 3 quarters · filed 2026-02-13
-$2.64M
10-K · filed 2026-02-13
2023-09-30$6.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$10.96M
derived: sum of 2 quarters · filed 2024-10-29
-$4.17M
10-Q · filed 2024-10-29
$108.00K
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$4.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$10.31M
10-Q · filed 2024-08-08
-$6.04M
derived: sum of 3 quarters · filed 2025-02-13
-$1.19M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$15.13M
10-Q · filed 2024-04-30
-$10.85M
derived: sum of 2 quarters · filed 2025-02-13
-$6.01M
derived: sum of 3 quarters · filed 2025-02-13
-$732.00K
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$4.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$9.12M
derived: sum of 2 quarters · filed 2025-02-13
$14.40M
derived: sum of 3 quarters · filed 2025-02-13
$1.11M
10-K · filed 2025-02-13
2022-09-30$4.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$10.12M
derived: sum of 2 quarters · filed 2023-11-03
-$3.16M
10-Q · filed 2023-11-03
$1.31M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30$5.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
-$8.01M
10-Q · filed 2023-08-04
-$3.54M
derived: sum of 3 quarters · filed 2024-02-15
$2.60M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31-$13.28M
10-Q · filed 2023-05-04
-$8.81M
derived: sum of 2 quarters · filed 2024-02-15
-$2.68M
derived: sum of 3 quarters · filed 2024-02-15
$1.75M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$4.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$10.61M
derived: sum of 2 quarters · filed 2024-02-15
$15.04M
derived: sum of 3 quarters · filed 2024-02-15
$16.34M
10-K · filed 2024-02-15
2021-09-30$6.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$10.57M
derived: sum of 2 quarters · filed 2022-11-03
$11.87M
10-Q · filed 2022-11-03
$16.09M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$4.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$5.73M
10-Q · filed 2022-08-09
$9.95M
derived: sum of 3 quarters · filed 2023-02-16
$10.76M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$1.30M
10-Q · filed 2022-05-05
$5.52M
derived: sum of 2 quarters · filed 2023-02-16
$6.33M
derived: sum of 3 quarters · filed 2023-02-16
-$1.95M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$4.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$5.03M
derived: sum of 2 quarters · filed 2023-02-16
-$3.25M
derived: sum of 3 quarters · filed 2023-02-16
$2.94M
10-K · filed 2023-02-16
2020-09-30$811.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$7.48M
derived: sum of 2 quarters · filed 2021-11-05
-$1.29M
10-Q · filed 2021-11-05
$3.17M
derived: sum of 4 quarters · filed 2022-02-18
2020-06-30-$8.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$2.10M
10-Q · filed 2021-08-06
$2.36M
derived: sum of 3 quarters · filed 2022-02-18
$3.84M
derived: sum of 4 quarters · filed 2022-02-18
2020-03-31$6.19M
10-Q · filed 2021-05-07
$10.64M
derived: sum of 2 quarters · filed 2022-02-18
$12.13M
derived: sum of 3 quarters · filed 2022-02-18
$11.45M
derived: sum of 4 quarters · filed 2022-02-18
2019-12-31$4.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
$5.94M
derived: sum of 2 quarters · filed 2022-02-18
$5.25M
derived: sum of 3 quarters · filed 2022-02-18
$5.29M
10-K · filed 2022-02-18
2019-09-30$1.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$800.00K
derived: sum of 2 quarters · filed 2020-11-12
$838.00K
10-Q · filed 2020-11-12
$3.64M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30-$683.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
-$645.00K
10-Q · filed 2020-08-12
$2.15M
derived: sum of 3 quarters · filed 2021-02-26
2019-03-31$38.00K
10-Q · filed 2020-05-12
$2.84M
derived: sum of 2 quarters · filed 2021-02-26
2018-12-31$2.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$2.60M
10-K · filed 2021-02-26
2018-09-30-$199.00K
10-Q · filed 2019-11-12
2017-12-31$3.50M
10-K · filed 2020-02-27